NasdaqGS:XRAY

Stock Analysis Report

Executive Summary

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide.

Snowflake

Fundamentals

Excellent balance sheet with moderate growth potential.


Similar Companies

Share Price & News

How has DENTSPLY SIRONA's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-2.5%

NasdaqGS:XRAY

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

29.1%

NasdaqGS:XRAY

9.9%

US Medical Equipment

1.6%

US Market

XRAY outperformed the Medical Equipment industry which returned 9.7% over the past year.

XRAY outperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

XRAYIndustryMarket
7 Day-2.5%0.5%-0.02%
30 Day-6.9%0.09%2.7%
90 Day-13.2%2.0%1.4%
1 Year30.2%29.1%10.8%9.9%3.8%1.6%
3 Year-15.1%-16.7%69.0%63.9%45.2%35.8%
5 Year11.0%7.9%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is DENTSPLY SIRONA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is DENTSPLY SIRONA undervalued based on future cash flows and its price relative to the stock market?

105.52x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

DENTSPLY SIRONA's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

DENTSPLY SIRONA's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

DENTSPLY SIRONA is overvalued based on earnings compared to the US Medical Equipment industry average.

DENTSPLY SIRONA is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

DENTSPLY SIRONA is poor value based on expected growth next year.


Price Based on Value of Assets

DENTSPLY SIRONA is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is DENTSPLY SIRONA expected to perform in the next 1 to 3 years based on estimates from 17 analysts?

33.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

DENTSPLY SIRONA's revenue is expected to grow by 3.3% yearly, however this is not considered high growth (20% yearly).

DENTSPLY SIRONA's earnings are expected to grow significantly at over 20% yearly.

DENTSPLY SIRONA's revenue growth is positive but not above the United States of America market average.

DENTSPLY SIRONA's earnings growth is expected to exceed the United States of America market average.

DENTSPLY SIRONA's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

DENTSPLY SIRONA is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has DENTSPLY SIRONA performed over the past 5 years?

-56.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

DENTSPLY SIRONA's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.

DENTSPLY SIRONA has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.

DENTSPLY SIRONA has become profitable in the last year making it difficult to compare the US Medical Equipment industry average.


Return on Equity

DENTSPLY SIRONA has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

DENTSPLY SIRONA used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

DENTSPLY SIRONA has improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is DENTSPLY SIRONA's financial position?


Financial Position Analysis

DENTSPLY SIRONA is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

DENTSPLY SIRONA's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

DENTSPLY SIRONA's level of debt (28.9%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (55.3% vs 28.9% today).

Debt is well covered by operating cash flow (33.6%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 9.9x coverage).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 1.2x debt.


Next Steps

Dividend

What is DENTSPLY SIRONA's current dividend yield, its reliability and sustainability?

0.75%

Expected Dividend Yield


Upcoming Dividend Payment

Purchase DENTSPLY SIRONA before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield and Payments Analysis

DENTSPLY SIRONA's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

DENTSPLY SIRONA's dividend is below the markets top 25% of dividend payers in United States of America (3.69%).

DENTSPLY SIRONA is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.

DENTSPLY SIRONA is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.


Current Payout to Shareholders

No need to calculate the sustainability of DENTSPLY SIRONA's dividends as it is not paying a notable one for United States of America.


Future Payout to Shareholders

No need to calculate the sustainability of DENTSPLY SIRONA's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of DENTSPLY SIRONA's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average management tenure


CEO

Don Casey (59yo)

1.6yrs

Tenure

US$11,338,542

Compensation

Mr. Donald M. Casey, Jr., also known as Don, serves as CEO and Director at DENTSPLY International Inc., since 2018. Mr. Casey has been Chief Executive Officer and a Director at Dentsply Sirona Inc. since  ...


CEO Compensation Analysis

Don's remuneration is about average for companies of similar size in United States of America.

Insufficient data for Don to compare compensation growth.


Management Age and Tenure

2.0yrs

Average Tenure

55yo

Average Age

The tenure for the DENTSPLY SIRONA management team is about average.


Board Age and Tenure

2.8yrs

Average Tenure

63.5yo

Average Age

The average tenure for the DENTSPLY SIRONA board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$150,43907 Jun 19
Betsy Holden
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares2,720
Max PriceUS$55.31
BuyUS$536,76930 May 19
Donald Casey
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares10,000
Max PriceUS$53.68
SellUS$102,05028 May 19
Michael Alfano
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares1,898
Max PriceUS$53.77
BuyUS$536,04723 May 19
Gregory Lucier
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares10,000
Max PriceUS$53.60
SellUS$1,226,61013 May 19
Maureen MacInnis
EntityIndividual
Role
Head of Human Resources
Senior VP
Shares22,302
Max PriceUS$55.00
SellUS$164,17510 May 19
William Newell
EntityIndividual
Role
Senior Key Executive
Senior Vice President of Chairside Consumables
Shares3,000
Max PriceUS$54.73
BuyUS$202,15207 May 19
Daniel Key
EntityIndividual
Shares3,697
Max PriceUS$54.68
SellUS$175,08115 Apr 19
Michael Alfano
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares2,632
Max PriceUS$66.52
SellUS$123,94104 Dec 18
Markus Boehringer
EntityIndividual
Role
Senior Key Executive
Senior Vice President of EMEA RCO
Shares3,273
Max PriceUS$37.87

Ownership Breakdown


Management Team

  • Don Casey (59yo)

    CEO & Director

    • Tenure: 1.6yrs
    • Compensation: US$11.34m
  • John Sweeney

    Vice President of Investor Relations

    • Tenure: 0yrs
  • Jorge Gomez (51yo)

    Executive VP & CFO

    • Tenure: 0.08yrs
  • Keith Ebling (50yo)

    EVP, General Counsel & Secretary

    • Tenure: 1.9yrs
    • Compensation: US$2.33m
  • Albert Sterkenburg (55yo)

    Senior Vice President

    • Tenure: 10.7yrs
    • Compensation: US$1.35m
  • Maureen MacInnis (58yo)

    Senior VP

    • Tenure: 10.4yrs
    • Compensation: US$1.09m
  • Markus Boehringer (55yo)

    Senior Vice President of EMEA RCO

    • Tenure: 2.2yrs
    • Compensation: US$1.52m
  • Teresa Dolan

    Chief Clinical Officer & VP

    • Tenure: 0yrs
  • Bill Newell (57yo)

    Senior Vice President of Chairside Consumables

    • Tenure: 2.2yrs
    • Compensation: US$1.48m
  • Cord Staehler

    Chief Technology Officer

    • Tenure: 0.3yrs

Board Members

  • Francis Lunger (73yo)

    Independent Director

    • Tenure: 14.3yrs
    • Compensation: US$282.50k
  • Eric Brandt (57yo)

    Non-Executive Chairman

    • Tenure: 2yrs
    • Compensation: US$398.88k
  • Harry M. Kraemer (64yo)

    Independent Director

    • Tenure: 3.6yrs
    • Compensation: US$270.00k
  • Betsy Holden (63yo)

    Independent Director

    • Tenure: 1.7yrs
    • Compensation: US$261.75k
  • Michael Alfano (71yo)

    Independent Director

    • Tenure: 18.6yrs
    • Compensation: US$270.00k
  • Leslie Varon (62yo)

    Independent Director

    • Tenure: 1.7yrs
    • Compensation: US$264.16k
  • Greg Lucier (55yo)

    Independent Director

    • Tenure: 0.3yrs
  • Arthur Kowaloff (72yo)

    Independent Director

    • Tenure: 3.6yrs
    • Compensation: US$272.50k
  • Don Casey (59yo)

    CEO & Director

    • Tenure: 1.6yrs
    • Compensation: US$11.34m
  • Willie Deese (64yo)

    Independent Director

    • Tenure: 8.6yrs
    • Compensation: US$272.50k

Company Information

DENTSPLY SIRONA Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: DENTSPLY SIRONA Inc.
  • Ticker: XRAY
  • Exchange: NasdaqGS
  • Founded: 1899
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$11.178b
  • Shares outstanding: 224.18m
  • Website: https://www.dentsplysirona.com

Number of Employees


Location

  • DENTSPLY SIRONA Inc.
  • 13320 Ballantyne Corporate Place
  • Charlotte
  • North Carolina
  • 28277
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
XRAYNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDAug 1987
DY2DB (Deutsche Boerse AG)YesCommon StockDEEURAug 1987
0I8FLSE (London Stock Exchange)YesCommon StockGBUSDAug 1987
XRAYWBAG (Wiener Boerse AG)YesCommon StockATEURAug 1987
XRAY34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH REP 1 COM USD0.01BRBRLMay 2019

Biography

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. T ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 23:34
End of Day Share Price2019/09/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.